Analysis of secreted proteins

Methods in Molecular Biology

Volumn 1002, Issue , 2013, Pages 37-60

  Severino, Valeria ^a   Farina, Annarita ^b   Chambery, Angela ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Biomarker discovery; Mass spectrometry; Proteomics; Quantitative LC MS; Secretome

Indexed keywords

THIOL;

ALKYLATION; APOPTOSIS; AUTOCRINE EFFECT; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DATA ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; VALIDATION PROCESS; WORKFLOW;

BIOLOGICAL MARKERS; CELL LINE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; HUMANS; INTENSIVE CARE UNITS, NEONATAL; PROTEINS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84885779237     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-360-2_4     Document Type: Review

References (88)

1. Pandey A, Mann M (2000) Proteomics to study genes and genomes. Nature 405: 837-846
2. Tyers M, Mann M (2003) From genomics to proteomics. Nature 422:193-197
3. May M (2009) From cells, secrets of the secretome leak out. Nat Med 15:828
4. Walter P, Gilmore R, Blobel G (1984) Protein translocation across the endoplasmic reticulum. Cell 38:5-8
5. Nickel W (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270:2109-2119
6. Karagiannis GS, Pavlou MP, Diamandis EP (2010) Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol Oncol 4:496-510
7. Makridakis M, Vlahou A (2010) Secretome proteomics for discovery of cancer biomarkers. J Proteomics 73:2291-2305
8. Xue H, Lu B, Lai M (2008) The cancer secretome: a reservoir of biomarkers. J Transl Med 6:1-12
9. Pavlou MP, Diamandis EP (2010) The cancer cell secretome: a good source for discovering biomarkers J Proteomics 73:1896-1906
10. Stastna M, Van Eyk JE (2012) Secreted proteins as a fundamental source for biomarker discovery. Proteomics 12:1-14
11. Dowling P, Clynes M (2011) Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of diseasespeci fi c biomarkers. Proteomics 11:794-804
12. Skalnikova H, Motlik J, Gadher SJ, Kovarova H (2011) Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 11:691-708
13. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS (2005) Biomarkers: mining the bio fl uid proteome. Mol Cell Proteomics 4: 409-418
14. Mischak H, Allmaier G, Apweiler R et al (2010) Recommendations for biomarker identi fi cation and quali fi cation in clinical proteomics. Sci Transl Med 2:46ps42
15. Lim JWE, Bodnar A (2002) Proteome analysis of conditioned medium from mouse embryonic fi broblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2: 1187-1203
16. Lee MJ, Kim J, Kim MY et al (2010) Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res 9:1754-1762
17. Rocco M, Malorni L, Cozzolino R et al (2011) Proteomic pro fi ling of human melanoma metastatic cell line secretomes. J Proteome Res 10: 4703-4714
18. Farina A, D'Aniello C, Severino V et al (2011) Temporal proteomic pro fi ling of embryonic stem cell secretome during cardiac and neural differentiation. Proteomics 11:3972-3982
19. Klein-Scory S, Kubler S, Diehl H et al (2010) Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 70:1-19
20. Srisomsap C, Sawangareetrakul P, Subhasitanont P et al (2010) Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010:437143
21. Tang CE, Guan YJ, Yi B et al (2010) Identi fi cation of the amyloid beta-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J Proteome Res 9:6101-6111
22. Del Galdo F, Shaw MA, Jimenez SA (2010) Proteomic analysis identi fi cation of a pattern of shared alterations in the secretome of dermal fi broblasts from systemic sclerosis and nephrogenic systemic fi brosis. Am J Pathol 177:1638-1646
23. Roca-Rivada A, Alonso J, Al-Massadi O et al (2011) Secretome analysis of rat adipose tissues shows location-speci fi c roles for each depot type. J Proteomics 74: 1068-1079
24. Mathias RA, Wang B, Ji H et al (2009) Secretome-based proteomic pro fi ling of Rastransformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. J Proteome Res 8:2827-2837
25. De la Fuente A, Mateos J, Lesende-Rodriguez I et al (2012) Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells. Mol Cell Proteomics 11:M111.010496
26. Weiss W, Gorg A (2009) High-resolution twodimensional electrophoresis. Methods Mol Biol 564:13-32
27. Mathias RA, Ji H, Simpson RJ (2012) Proteomic pro fi ling of the epithelial-mesenchymal transition using 2D DIGE. Methods Mol Biol 854:269-286
28. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:2856-2860
29. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S (2004) Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 17:349-356
30. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:783-795
31. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B (2007) Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 389:1017-1031
32. Ong SE, Blagoev B, Kratchmarova I et al (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376-386
33. May C, Brosseron F, Chartowski P, Schumbrutzki C, Schoenebeck B, Marcus K (2011) Instruments and methods in proteomics. Methods Mol Biol 696:3-26
34. Brewis IA, Brennan P (2010) Proteomics technologies for the global identi fi cation and quanti fi cation of proteins. Adv Protein Chem Struct Biol 80:1-44
35. Mann M (2006) Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 7:952-958
36. Chen CY, Chi LM, Chi HC et al (2012) Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells. Mol Cell Proteomics 11:M111.011270
37. Kashyap MK, Harsha HC, Renuse S et al (2010) SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. Cancer Biol Ther 10:796-810
38. Gronborg M, Kristiansen TZ, Iwahori A et al (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5:157-171
39. Formolo CA, Williams R, Gordish-Dressman H, MacDonald TJ, Lee NH, Hathout Y (2011) Secretome signature of invasive glioblastoma multiforme. J Proteome Res 10:3149-3159
40. Calamia V, Rocha B, Mateos J, Fernandez- Puente P, Ruiz-Romero C, Blanco FJ (2011) Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-betamediated modulation of their intracellular and extracellular proteomes. J Proteome Res 10:3701-3711
41. Greco TM, Seeholzer SH, Mak A, Spruce L, Ischiropoulos H (2010) Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res 9:2764-2774
42. Chan CY, Masui O, Krakovska O et al (2011) Identi fi cation of differentially regulated secretome components during skeletal myogenesis. Mol Cell Proteomics 10:M110.004804
43. Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I (2010) Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 9: 2482-2496
44. Ross PL, Huang YN, Marchese JN et al (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154-1169
45. Chenau J, Michelland S, de Fraipont F et al (2009) The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53- modulated proteins secreted in lung cancer cells. J Proteome Res 8:4579-4591
46. Chiu KH, Chang YH, Wu YS, Lee SH, Liao PC (2011) Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided puri fi cation combined with iTRAQ labeling. J Proteome Res 10:1110-1125
47. Lietzen N, Ohman T, Rintahaka J et al (2011) Quantitative subcellular proteome and secretome pro fi ling of in fl uenza A virus-infected human primary macrophages. PLoS Pathog 7:e1001340
48. Zhong J, Krawczyk SA, Chaerkady R et al (2010) Temporal pro fi ling of the secretome during adipogenesis in humans. J Proteome Res 9:5228-5238
49. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded af fi nity tags. Nat Biotechnol 17:994-999
50. Khwaja FW, Svoboda P, Reed M, Pohl J, Pyrzynska B, Van Meir EG (2006) Proteomic identi fi cation of the wt-p53-regulated tumor cell secretome. Oncogene 25:7650-7661
51. Pocsfalvi G, Votta G, De Vincenzo A et al (2011) Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. J Proteome Res 10:5326-5337
52. Bonzon-Kulichenko E, Martinez-Martinez S, Trevisan-Herraz M, Navarro P, Redondo JM, Vazquez J (2011) Quantitative in-depth analysis of the dynamic secretome of activated Jurkat T-cells. J Proteomics 75:561-571
53. Roelofsen H, Dijkstra M, Weening D, de Vries MP, Hoek A, Vonk RJ (2009) Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Mol Cell Proteomics 8:316-324
54. Bondarenko PV, Chelius D, Shaler TA (2002) Identi fi cation and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography- tandem mass spectrometry. Anal Chem 74:4741-4749
55. Chelius D, Bondarenko PV (2002) Quantitative pro fi ling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 1:317-323
56. Wang W, Zhou H, Lin H et al (2003) Quanti fi cation of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem 75:4818-4826
57. Ishihama Y, Oda Y, Tabata T et al (2005) Exponentially modi fi ed protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4:1265-1272
58. Lu P, Vogel C, Wang R, Yao X, Marcotte EM (2007) Absolute protein expression pro fi ling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol 25:117-124
59. Malard V, Chardan L, Roussi S et al (2012) Analytical constraints for the analysis of human cell line secretomes by shotgun proteomics. J Proteomics 75:1043-1054
60. Xue H, Lu B, Zhang J et al (2010) Identi fi cation of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 9:545-555
61. Gao BB, Stuart L, Feener EP (2008) Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome. Mol Cell Proteomics 7:2399-2409
62. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971-983
63. Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730
64. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK (2009) Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1229-1239
65. Mbeunkui F, Fodstad O, Pannell LK (2006) Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res 5:899-906
66. Yao L, Zhang Y, Chen K, Hu X, Xu LX (2011) Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox. PLoS One 6:e24684
67. Schiarea S, Solinas G, Allavena P et al (2010) Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks. J Proteome Res 9: 4376-4392
68. Pellitteri-Hahn MC, Warren MC, Didier DN et al (2006) Improved mass spectrometric proteomic pro fi ling of the secretome of rat vascular endothelial cells. J Proteome Res 5: 2861-2864
69. Alvarez-Llamas G, Szalowska E, de Vries MP et al (2007) Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 6:589-600
70. Stastna M, Chimenti I, Marban E, Van Eyk JE (2010) Identi fi cation and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 10:245-253
71. Pirkmajer S, Chibalin AV (2011) Serum starvation: caveat emptor. Am J Physiol Cell Physiol 301:C272-C279
72. Hasan NM, Adams GE, Joiner MC (1999) Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: implications for cell death. Int J Cancer 80:400-405
73. Keene SD, Greco TM, Parastatidis I et al (2009) Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics 9:768-782
74. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
75. Phillips HJ, Terryberry JE (1957) Counting actively metabolizing tissue cultured cells. Exp Cell Res 13:341-347
76. Weng LP, Wu CC, Hsu BL et al (2008) Secretome-based identi fi cation of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res 7:3765-3775
77. Dowell JA, Johnson JA, Li L (2009) Identi fi cation of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J Proteome Res 8: 4135-4143
78. Polisetty RV, Gupta MK, Nair SC et al (2011) Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins. J Proteomics 74:1918-1925
79. Wu CC, Hsu CW, Chen CD et al (2010) Candidate serological biomarkers for cancer identi fi ed from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 9:1100-1117
80. Caccia D, Zanetti Domingues L, Micciche F et al (2011) Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. J Proteome Res 10:4196-4207
81. Yoon JH, Yea K, Kim J et al (2009) Comparative proteomic analysis of the insulin-induced L6 myotube secretome. Proteomics 9:51-60
82. Canals F, Colome N, Ferrer C, Plaza-Calonge Mdel C, Rodriguez-Manzaneque JC (2006) Identi fi cation of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics 6(Suppl 1):S28-S35
83. Chevallet M, Diemer H, Luche S, van Dorsselaer A, Rabilloud T, Leize-Wagner E (2006) Improved mass spectrometry compatibility is afforded by ammoniacal silver staining. Proteomics 6:2350-2354
84. Kashat L, So AK, Masui O et al (2010) Secretomebased identi fi cation and characterization of potential biomarkers in thyroid cancer. J Proteome Res 9:5757-5769
85. Ralhan R, Masui O, Desouza LV, Matta A, Macha M, Siu KW (2011) Identi fi cation of proteins secreted by head and neck cancer cell lines using LC-MS/MS: strategy for discovery of candidate serological biomarkers. Proteomics 11:2363-2376
86. Luo X, Liu Y, Wang R, Hu H, Zeng R, Chen H (2011) A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer. J Proteomics 74: 528-538
87. Wang CL, Wang CI, Liao PC et al (2009) Discovery of retinoblastoma- associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res 8:4428-4440
88. Chang KP, Wu CC, Chen HC et al (2010) Identi fi cation of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics 10:2644-2660